TABLE 1.
Baseline characteristics of patients with UC and the outcomes after treatment by FMT
| Characteristica | Result for UC patients (n = 22)b |
|---|---|
| Sex, no. (%) | |
| Women | 3 (13.6) |
| Men | 19 (86.4) |
| Age, yr, mean (range) | 42.5 (20–68) |
| Left-sided disease only, no. (%) | 7 (31.8) |
| Total Mayo score | 7.62 (4–12) |
| Inflammatory markers, mean (range) | |
| CRP, mg/L | 5.03 (0.15–64.89) |
| ESR, mm/h | 14.42 (0.2–30.7) |
| WBC count, 10 × 9/L | 7.7 (3.62–18.12) |
| Neutrophil count, 10 × 9/L | 4.96 (1.48–14.13) |
| Neutrophil ratio, % (range) | 60.09 (38.3–75.3) |
| Outcomes, no. (%) | |
| Clinical response | 16 (76.2) |
| Clinical remission | 12 (57.1) |
| Endoscopic remission | 10 (47.6) |
a
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC count, white blood cell count.
b
The efficacy analysis included 21 patients, excluding 1 patient who lost communication during the study.